|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 201 to 300 out of 2703 for Dmd

0.029s

Categories

Hits by Pathway

Hits by Category

Hits by Strain

Type Details Score
Publication
First Author: Mann CJ
Year: 2001
Journal: Proc Natl Acad Sci U S A
Title: Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse.
Volume: 98
Issue: 1
Pages: 42-7
Publication
First Author: Sanson M
Year: 2020
Journal: Sci Rep
Title: miR-379 links glucocorticoid treatment with mitochondrial response in Duchenne muscular dystrophy.
Volume: 10
Issue: 1
Pages: 9139
Publication  
First Author: Casarrubea M
Year: 2020
Journal: Behav Brain Res
Title: Early alterations of the behavioural structure of mice affected by Duchenne muscular dystrophy and tested in open-field.
Volume: 386
Pages: 112609
Publication
First Author: Gaglianone RB
Year: 2019
Journal: Sci Rep
Title: Reduced mitochondrial respiration and increased calcium deposits in the EDL muscle, but not in soleus, from 12-week-old dystrophic mdx mice.
Volume: 9
Issue: 1
Pages: 1986
Publication
First Author: Asselin I
Year: 1995
Journal: Muscle Nerve
Title: Quantification of normal dystrophin mRNA following myoblast transplantation in mdx mice.
Volume: 18
Issue: 9
Pages: 980-6
Publication  
First Author: Moore TM
Year: 2020
Journal: Front Physiol
Title: Mitochondrial Dysfunction Is an Early Consequence of Partial or Complete Dystrophin Loss in mdx Mice.
Volume: 11
Pages: 690
Publication  
First Author: Bianchi R
Year: 2020
Journal: Mol Cell Neurosci
Title: Hippocampal synaptic and membrane function in the DBA/2J-mdx mouse model of Duchenne muscular dystrophy.
Volume: 104
Pages: 103482
Publication
First Author: Trivedi RA
Year: 1995
Journal: J Neurochem
Title: Liposome-mediated gene transfer into normal and dystrophin-deficient mouse myoblasts.
Volume: 64
Issue: 5
Pages: 2230-8
Publication
First Author: Pigozzo SR
Year: 2013
Journal: PLoS One
Title: Revertant fibers in the mdx murine model of Duchenne muscular dystrophy: an age- and muscle-related reappraisal.
Volume: 8
Issue: 8
Pages: e72147
Publication
First Author: Ng SY
Year: 2023
Journal: FASEB J
Title: Acute, next-generation AMPK activation initiates a disease-resistant gene expression program in dystrophic skeletal muscle.
Volume: 37
Issue: 5
Pages: e22863
Publication
First Author: Stelter Z
Year: 2016
Journal: Am J Physiol Heart Circ Physiol
Title: Hypoxia-induced cardiac injury in dystrophic mice.
Volume: 310
Issue: 7
Pages: H938-48
Publication
First Author: Kendall GC
Year: 2012
Journal: Sci Transl Med
Title: Dantrolene enhances antisense-mediated exon skipping in human and mouse models of Duchenne muscular dystrophy.
Volume: 4
Issue: 164
Pages: 164ra160
Publication
First Author: Hardee JP
Year: 2021
Journal: Am J Physiol Cell Physiol
Title: Dystrophin deficiency disrupts muscle clock expression and mitochondrial quality control in mdx mice.
Volume: 321
Issue: 2
Pages: C288-C296
Publication
First Author: Apolinário LM
Year: 2015
Journal: Anat Rec (Hoboken)
Title: Long-Term Therapy With Omega-3 Ameliorates Myonecrosis and Benefits Skeletal Muscle Regeneration in Mdx Mice.
Volume: 298
Issue: 9
Pages: 1589-96
Publication
First Author: Fiacco E
Year: 2016
Journal: Cell Death Differ
Title: Autophagy regulates satellite cell ability to regenerate normal and dystrophic muscles.
Volume: 23
Issue: 11
Pages: 1839-1849
Publication
First Author: Timpani CA
Year: 2020
Journal: Sci Rep
Title: Adenylosuccinic acid therapy ameliorates murine Duchenne Muscular Dystrophy.
Volume: 10
Issue: 1
Pages: 1125
Publication
First Author: Barker RG
Year: 2018
Journal: Am J Physiol Cell Physiol
Title: Mitochondrial content is preserved throughout disease progression in the mdx mouse model of Duchenne muscular dystrophy, regardless of taurine supplementation.
Volume: 314
Issue: 4
Pages: C483-C491
Publication
First Author: Messina S
Year: 2006
Journal: Am J Pathol
Title: Lipid peroxidation inhibition blunts nuclear factor-kappaB activation, reduces skeletal muscle degeneration, and enhances muscle function in mdx mice.
Volume: 168
Issue: 3
Pages: 918-26
Publication
First Author: Hassani M
Year: 2024
Journal: PLoS One
Title: Beneficial effects of resistance training on both mild and severe mouse dystrophic muscle function as a preclinical option for Duchenne muscular dystrophy.
Volume: 19
Issue: 3
Pages: e0295700
Publication    
First Author: Spitali P
Year: 2013
Journal: PLoS Curr
Title: Autophagy is Impaired in the Tibialis Anterior of Dystrophin Null Mice.
Volume: 5
Publication
First Author: Wasala NB
Year: 2016
Journal: Hum Mol Genet
Title: Genomic removal of a therapeutic mini-dystrophin gene from adult mice elicits a Duchenne muscular dystrophy-like phenotype.
Volume: 25
Issue: 13
Pages: 2633-2644
Publication  
First Author: Lombardi L
Year: 2017
Journal: Mol Cell Neurosci
Title: NGF-dependent axon growth and regeneration are altered in sympathetic neurons of dystrophic mdx mice.
Volume: 80
Pages: 1-17
Publication
First Author: Khairallah RJ
Year: 2012
Journal: Sci Signal
Title: Microtubules underlie dysfunction in duchenne muscular dystrophy.
Volume: 5
Issue: 236
Pages: ra56
Publication
First Author: Gilbert R
Year: 2003
Journal: Hum Mol Genet
Title: Prolonged dystrophin expression and functional correction of mdx mouse muscle following gene transfer with a helper-dependent (gutted) adenovirus-encoding murine dystrophin.
Volume: 12
Issue: 11
Pages: 1287-99
Publication  
First Author: Engelbeen S
Year: 2020
Journal: Front Behav Neurosci
Title: Assessment of Behavioral Characteristics With Procedures of Minimal Human Interference in the mdx Mouse Model for Duchenne Muscular Dystrophy.
Volume: 14
Pages: 629043
Publication  
First Author: Achlaug L
Year: 2023
Journal: Int J Mol Sci
Title: Tumor Growth Ameliorates Cardiac Dysfunction and Suppresses Fibrosis in a Mouse Model for Duchenne Muscular Dystrophy.
Volume: 24
Issue: 16
Publication
First Author: Signorelli M
Year: 2021
Journal: EMBO Mol Med
Title: Peripheral blood transcriptome profiling enables monitoring disease progression in dystrophic mice and patients.
Volume: 13
Issue: 4
Pages: e13328
Publication
First Author: Vaillend C
Year: 1999
Journal: Neuromuscul Disord
Title: Behavioral characterization of mdx3cv mice deficient in C-terminal dystrophins.
Volume: 9
Issue: 5
Pages: 296-304
Publication
First Author: Cascabulho CM
Year: 2012
Journal: Am J Pathol
Title: Defective T-lymphocyte migration to muscles in dystrophin-deficient mice.
Volume: 181
Issue: 2
Pages: 593-604
Publication  
First Author: Sandonà M
Year: 2023
Journal: Int J Mol Sci
Title: Amniotic Membrane-Derived Stromal Cells Release Extracellular Vesicles That Favor Regeneration of Dystrophic Skeletal Muscles.
Volume: 24
Issue: 15
Publication
First Author: Wang H
Year: 2021
Journal: Hum Mol Genet
Title: Proteomic analysis identifies key differences in the cardiac interactomes of dystrophin and micro-dystrophin.
Volume: 30
Issue: 14
Pages: 1321-1336
Publication
First Author: Bostick B
Year: 2009
Journal: Mol Ther
Title: Cardiac expression of a mini-dystrophin that normalizes skeletal muscle force only partially restores heart function in aged Mdx mice.
Volume: 17
Issue: 2
Pages: 253-61
Publication
First Author: Catalani E
Year: 2021
Journal: Cell Mol Life Sci
Title: Defects of full-length dystrophin trigger retinal neuron damage and synapse alterations by disrupting functional autophagy.
Volume: 78
Issue: 4
Pages: 1615-1636
Publication  
First Author: Yoon SH
Year: 2019
Journal: Bone
Title: Intermittent PTH treatment improves bone and muscle in glucocorticoid treated Mdx mice: A model of Duchenne Muscular Dystrophy.
Volume: 121
Pages: 232-242
Publication
First Author: Morici G
Year: 2016
Journal: J Cell Physiol
Title: Lack of Dystrophin Affects Bronchial Epithelium in mdx Mice.
Volume: 231
Issue: 10
Pages: 2218-23
Publication
First Author: Moorwood C
Year: 2014
Journal: Hum Mol Genet
Title: Caspase-12 ablation preserves muscle function in the mdx mouse.
Volume: 23
Issue: 20
Pages: 5325-41
Publication
First Author: Yue Y
Year: 2004
Journal: Hum Mol Genet
Title: Full-length dystrophin expression in half of the heart cells ameliorates beta-isoproterenol-induced cardiomyopathy in mdx mice.
Volume: 13
Issue: 15
Pages: 1669-75
Publication
First Author: Morales ED
Year: 2023
Journal: J Am Heart Assoc
Title: Dwarf Open Reading Frame (DWORF) Gene Therapy Ameliorated Duchenne Muscular Dystrophy Cardiomyopathy in Aged mdx Mice.
Volume: 12
Issue: 3
Pages: e027480
Publication
First Author: Martin PT
Year: 2021
Journal: Am J Pathol
Title: Serum Antibodies to N-Glycolylneuraminic Acid Are Elevated in Duchenne Muscular Dystrophy and Correlate with Increased Disease Pathology in Cmah-/-mdx Mice.
Volume: 191
Issue: 8
Pages: 1474-1486
Publication
First Author: Nguyen-Tran DH
Year: 2014
Journal: Dis Model Mech
Title: Molecular mechanism of sphingosine-1-phosphate action in Duchenne muscular dystrophy.
Volume: 7
Issue: 1
Pages: 41-54
Publication
First Author: Dubinin MV
Year: 2020
Journal: Biochim Biophys Acta Mol Basis Dis
Title: Duchenne muscular dystrophy is associated with the inhibition of calcium uniport in mitochondria and an increased sensitivity of the organelles to the calcium-induced permeability transition.
Volume: 1866
Issue: 5
Pages: 165674
Publication  
First Author: Saoudi A
Year: 2021
Journal: Dis Model Mech
Title: Emotional behavior and brain anatomy of the mdx52 mouse model of Duchenne muscular dystrophy.
Volume: 14
Issue: 9
Publication
First Author: Guiraud S
Year: 2019
Journal: Hum Mol Genet
Title: Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMD.
Volume: 28
Issue: 2
Pages: 307-319
Publication  
First Author: Gao Z
Year: 2021
Journal: Biomolecules
Title: Partial Ablation of Non-Myogenic Progenitor Cells as a Therapeutic Approach to Duchenne Muscular Dystrophy.
Volume: 11
Issue: 10
Publication
First Author: Schomaker S
Year: 2020
Journal: PLoS One
Title: Serum glutamate dehydrogenase activity enables early detection of liver injury in subjects with underlying muscle impairments.
Volume: 15
Issue: 5
Pages: e0229753
Publication
First Author: Whitehead NP
Year: 2015
Journal: Proc Natl Acad Sci U S A
Title: A new therapeutic effect of simvastatin revealed by functional improvement in muscular dystrophy.
Volume: 112
Issue: 41
Pages: 12864-9
Publication
First Author: Mu X
Year: 2017
Journal: Hum Mol Genet
Title: RhoA/ROCK inhibition improves the beneficial effects of glucocorticoid treatment in dystrophic muscle: implications for stem cell depletion.
Volume: 26
Issue: 15
Pages: 2813-2824
Publication  
First Author: Stay TL
Year: 2019
Journal: Dis Model Mech
Title: In vivo cerebellar circuit function is disrupted in an mdx mouse model of Duchenne muscular dystrophy.
Volume: 13
Issue: 2
Publication  
First Author: Podkalicka P
Year: 2020
Journal: JCI Insight
Title: Lack of miR-378 attenuates muscular dystrophy in mdx mice.
Volume: 5
Issue: 11
Publication
First Author: Shao W
Year: 2018
Journal: Hum Mol Genet
Title: Inhibition of antigen presentation during AAV gene therapy using virus peptides.
Volume: 27
Issue: 4
Pages: 601-613
Publication
First Author: Chu X
Year: 2021
Journal: FASEB J
Title: Long-term effect of human mini-dystrophin in transgenic mdx mice improves muscle physiological function.
Volume: 35
Issue: 6
Pages: e21628
Publication
First Author: Coles CA
Year: 2020
Journal: Hum Mol Genet
Title: Expression profiling in exercised mdx suggests a role for extracellular proteins in the dystrophic muscle immune response.
Volume: 29
Issue: 3
Pages: 353-368
Publication
First Author: Kumar A
Year: 2010
Journal: Am J Pathol
Title: Matrix metalloproteinase inhibitor batimastat alleviates pathology and improves skeletal muscle function in dystrophin-deficient mdx mice.
Volume: 177
Issue: 1
Pages: 248-60
Publication  
First Author: Cernisova V
Year: 2023
Journal: Int J Mol Sci
Title: Microdystrophin Gene Addition Significantly Improves Muscle Functionality and Diaphragm Muscle Histopathology in a Fibrotic Mouse Model of Duchenne Muscular Dystrophy.
Volume: 24
Issue: 9
Publication
First Author: Vulin A
Year: 2015
Journal: Neuromuscul Disord
Title: The first exon duplication mouse model of Duchenne muscular dystrophy: A tool for therapeutic development.
Volume: 25
Issue: 11
Pages: 827-34
Publication
First Author: Lefaucheur JP
Year: 1995
Journal: Anat Rec
Title: Phenotype of dystrophinopathy in old mdx mice.
Volume: 242
Issue: 1
Pages: 70-6
Publication  
First Author: Russell AJ
Year: 2023
Journal: J Clin Invest
Title: Modulating fast skeletal muscle contraction protects skeletal muscle in animal models of Duchenne muscular dystrophy.
Volume: 133
Issue: 10
Publication
First Author: Starikova AV
Year: 2022
Journal: Sci Rep
Title: Therapeutic potential of highly functional codon-optimized microutrophin for muscle-specific expression.
Volume: 12
Issue: 1
Pages: 848
Publication
First Author: Bronisz-Budzyńska I
Year: 2019
Journal: Skelet Muscle
Title: miR-146a deficiency does not aggravate muscular dystrophy in mdx mice.
Volume: 9
Issue: 1
Pages: 22
Publication  
First Author: Svetlove A
Year: 2022
Journal: Cells
Title: Non-Invasive Optical Motion Tracking Allows Monitoring of Respiratory Dynamics in Dystrophin-Deficient Mice.
Volume: 11
Issue: 5
Publication    
First Author: Gosselin MRF
Year: 2022
Journal: Elife
Title: Loss of full-length dystrophin expression results in major cell-autonomous abnormalities in proliferating myoblasts.
Volume: 11
Publication
First Author: Cao L
Year: 2014
Journal: PLoS One
Title: Wild-type mouse models to screen antisense oligonucleotides for exon-skipping efficacy in Duchenne muscular dystrophy.
Volume: 9
Issue: 11
Pages: e111079
Publication
First Author: Ahmad A
Year: 2000
Journal: Hum Mol Genet
Title: Mdx mice inducibly expressing dystrophin provide insights into the potential of gene therapy for duchenne muscular dystrophy.
Volume: 9
Issue: 17
Pages: 2507-15
Publication  
First Author: Matias-Valiente L
Year: 2024
Journal: Biomed Pharmacother
Title: Evaluation of pro-regenerative and anti-inflammatory effects of isolecanoric acid in the muscle: Potential treatment of Duchenne Muscular Dystrophy.
Volume: 170
Pages: 116056
Publication
First Author: Rybalka E
Year: 2014
Journal: PLoS One
Title: Defects in mitochondrial ATP synthesis in dystrophin-deficient mdx skeletal muscles may be caused by complex I insufficiency.
Volume: 9
Issue: 12
Pages: e115763
Publication
First Author: Barton-Davis ER
Year: 1999
Journal: J Clin Invest
Title: Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice.
Volume: 104
Issue: 4
Pages: 375-81
Publication
First Author: Terrill JR
Year: 2020
Journal: PLoS One
Title: Oxidative damage to urinary proteins from the GRMD dog and mdx mouse as biomarkers of dystropathology in Duchenne muscular dystrophy.
Volume: 15
Issue: 10
Pages: e0240317
Publication
First Author: Vaillend C
Year: 2017
Journal: Hum Mol Genet
Title: Relationships linking emotional, motor, cognitive and GABAergic dysfunctions in dystrophin-deficient mdx mice.
Volume: 26
Issue: 6
Pages: 1041-1055
Publication
First Author: Fontelonga TM
Year: 2019
Journal: Hum Mol Genet
Title: Sunitinib promotes myogenic regeneration and mitigates disease progression in the mdx mouse model of Duchenne muscular dystrophy.
Volume: 28
Issue: 13
Pages: 2120-2132
Publication
First Author: Kao BR
Year: 2021
Journal: Nucleic Acid Ther
Title: Knockdown of Muscle-Specific Ribosomal Protein L3-Like Enhances Muscle Function in Healthy and Dystrophic Mice.
Volume: 31
Issue: 6
Pages: 457-464
Publication  
First Author: Rossi R
Year: 2021
Journal: Front Physiol
Title: Circadian Genes as Exploratory Biomarkers in DMD: Results From Both the mdx Mouse Model and Patients.
Volume: 12
Pages: 678974
Publication  
First Author: Mucha O
Year: 2023
Journal: Biomolecules
Title: Proteome Profiling of the Dystrophic mdx Mice Diaphragm.
Volume: 13
Issue: 11
Publication
First Author: Morin S
Year: 1995
Journal: Differentiation
Title: Inhibition of proliferation in 8-week-old mdx mouse muscle fibroblasts in vitro.
Volume: 59
Issue: 3
Pages: 145-54
Publication  
First Author: De Giorgio D
Year: 2023
Journal: Int J Mol Sci
Title: Characterization of the Cardiac Structure and Function of Conscious D2.B10-Dmd(mdx)/J (D2-mdx) mice from 16-17 to 24-25 Weeks of Age.
Volume: 24
Issue: 14
Publication
First Author: Thangarajh M
Year: 2019
Journal: PLoS One
Title: Discovery of potential urine-accessible metabolite biomarkers associated with muscle disease and corticosteroid response in the mdx mouse model for Duchenne.
Volume: 14
Issue: 7
Pages: e0219507
Publication
First Author: Hirata T
Year: 2024
Journal: PLoS One
Title: Chloroquine decreases cardiac fibrosis and improves cardiac function in a mouse model of Duchenne muscular dystrophy.
Volume: 19
Issue: 1
Pages: e0297083
Publication
First Author: Percival JM
Year: 2013
Journal: Hum Mol Genet
Title: Defects in mitochondrial localization and ATP synthesis in the mdx mouse model of Duchenne muscular dystrophy are not alleviated by PDE5 inhibition.
Volume: 22
Issue: 1
Pages: 153-67
Publication
First Author: Chandrasekharan K
Year: 2010
Journal: Sci Transl Med
Title: A human-specific deletion in mouse Cmah increases disease severity in the mdx model of Duchenne muscular dystrophy.
Volume: 2
Issue: 42
Pages: 42ra54
Publication  
First Author: Pelosi L
Year: 2015
Journal: Front Aging Neurosci
Title: MicroRNAs modulated by local mIGF-1 expression in mdx dystrophic mice.
Volume: 7
Pages: 69
Publication
First Author: Mâncio RD
Year: 2017
Journal: PLoS One
Title: Dystrophic phenotype improvement in the diaphragm muscle of mdx mice by diacerhein.
Volume: 12
Issue: 8
Pages: e0182449
Publication
First Author: Podkalicka P
Year: 2022
Journal: Sci Rep
Title: miR-378 affects metabolic disturbances in the mdx model of Duchenne muscular dystrophy.
Volume: 12
Issue: 1
Pages: 3945
Publication  
First Author: Merckx C
Year: 2022
Journal: Int J Mol Sci
Title: Description of Osmolyte Pathways in Maturing Mdx Mice Reveals Altered Levels of Taurine and Sodium/Myo-Inositol Co-Transporters.
Volume: 23
Issue: 6
Publication
First Author: Kuno A
Year: 2018
Journal: Sci Rep
Title: Resveratrol Ameliorates Mitophagy Disturbance and Improves Cardiac Pathophysiology of Dystrophin-deficient mdx Mice.
Volume: 8
Issue: 1
Pages: 15555
Publication
First Author: Ghahramani Seno MM
Year: 2008
Journal: Hum Mol Genet
Title: RNAi-mediated knockdown of dystrophin expression in adult mice does not lead to overt muscular dystrophy pathology.
Volume: 17
Issue: 17
Pages: 2622-32
Publication
First Author: Wells DJ
Year: 1992
Journal: Hum Mol Genet
Title: Human dystrophin expression corrects the myopathic phenotype in transgenic mdx mice.
Volume: 1
Issue: 1
Pages: 35-40
Publication
First Author: Colussi C
Year: 2009
Journal: FASEB J
Title: Nitric oxide deficiency determines global chromatin changes in Duchenne muscular dystrophy.
Volume: 23
Issue: 7
Pages: 2131-41
Publication  
First Author: Turk R
Year: 2005
Journal: BMC Genomics
Title: Muscle regeneration in dystrophin-deficient mdx mice studied by gene expression profiling.
Volume: 6
Pages: 98
Publication  
First Author: Uryash A
Year: 2021
Journal: Front Physiol
Title: Cardioprotective Effect of Whole Body Periodic Acceleration in Dystrophic Phenotype mdx Rodent.
Volume: 12
Pages: 658042
Publication
First Author: Zhao J
Year: 2016
Journal: Hum Mol Genet
Title: Dystrophin contains multiple independent membrane-binding domains.
Volume: 25
Issue: 17
Pages: 3647-3653
Publication
First Author: Murphy KT
Year: 2010
Journal: Am J Pathol
Title: Antibody-directed myostatin inhibition improves diaphragm pathology in young but not adult dystrophic mdx mice.
Volume: 176
Issue: 5
Pages: 2425-34
Publication
First Author: Nio Y
Year: 2017
Journal: FASEB J
Title: Phosphodiesterase 4 inhibitor and phosphodiesterase 5 inhibitor combination therapy has antifibrotic and anti-inflammatory effects in mdx mice with Duchenne muscular dystrophy.
Volume: 31
Issue: 12
Pages: 5307-5320
Publication
First Author: Matsumura CY
Year: 2013
Journal: PLoS One
Title: Isobaric Tagging-Based Quantification for Proteomic Analysis: A Comparative Study of Spared and Affected Muscles from mdx Mice at the Early Phase of Dystrophy.
Volume: 8
Issue: 6
Pages: e65831
Publication
First Author: Kim JH
Year: 2012
Journal: Free Radic Biol Med
Title: Amplification of proinflammatory phenotype, damage, and weakness by oxidative stress in the diaphragm muscle of mdx mice.
Volume: 52
Issue: 9
Pages: 1597-606
Publication
First Author: Fukada S
Year: 2010
Journal: Am J Pathol
Title: Genetic background affects properties of satellite cells and mdx phenotypes.
Volume: 176
Issue: 5
Pages: 2414-24
Publication
First Author: Signorelli M
Year: 2023
Journal: PLoS One
Title: Multiomic characterization of disease progression in mice lacking dystrophin.
Volume: 18
Issue: 3
Pages: e0283869
Publication
First Author: Welch RD
Year: 2017
Journal: Sci Rep
Title: Pharmacological inhibition of REV-ERB stimulates differentiation, inhibits turnover and reduces fibrosis in dystrophic muscle.
Volume: 7
Issue: 1
Pages: 17142
Publication
First Author: Tsai TI
Year: 2016
Journal: Invest Ophthalmol Vis Sci
Title: Asymmetrical Functional Deficits of ON and OFF Retinal Processing in the mdx3Cv Mouse Model of Duchenne Muscular Dystrophy.
Volume: 57
Issue: 13
Pages: 5788-5798
Publication
First Author: Adamo CM
Year: 2010
Journal: Proc Natl Acad Sci U S A
Title: Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy.
Volume: 107
Issue: 44
Pages: 19079-83
Publication
First Author: Chang AC
Year: 2016
Journal: Proc Natl Acad Sci U S A
Title: Telomere shortening and metabolic compromise underlie dystrophic cardiomyopathy.
Volume: 113
Issue: 46
Pages: 13120-13125
Publication
First Author: Banks GB
Year: 2020
Journal: PLoS Genet
Title: Microutrophin expression in dystrophic mice displays myofiber type differences in therapeutic effects.
Volume: 16
Issue: 11
Pages: e1009179